• Yoann Zerbib, Antoine Rabbat, Muriel Fartoukh, Naïke Bigé, Claire Andréjak, Julien Mayaux, Nicolas De Prost, Benoît Misset, Virginie Lemiale, Fabrice Bruneel, Julien Maizel, Sylvie Ricome, Frédéric Jacobs, Caroline Bornstain, Hervé Dupont, François Baudin, Elie Azoulay, Frédéric Pène, and Groupe de Recherche sur la Réanimation Respiratoire en Onco-Hématologie (GRRR-OH).
• 1Réanimation médicale, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris & Université Paris Descartes, Paris, France.2Pneumologie et Soins Intensifs Respiratoires, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.3Réanimation Médico-chirurgicale, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.4Réanimation médicale, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.5Pneumologie et réanimation respiratoire, Centre Hospitalier Universitaire d'Amiens, Amiens, France.6Réanimation médicale et Unité de Soins Continus, Hôpital Pitié Salpetrière, Assistance Publique-Hôpitaux de Paris, Paris, France.7Réanimation médicale, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Paris, France.8Médecine intensive et Réanimation, Groupe hospitalier Paris Saint-Joseph, Paris, France.9Réanimation médicale, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.10Réanimation Médico-Chirurgicale, Centre Hospitalier André Mignot, Versailles, France.11Réanimation médicale, Centre Hospitalier Universitaire d'Amiens, Amiens, France.12Réanimation Polyvalente, Hôpital Robert Ballanger, Aulnay-sous-Bois, France.13Réanimation Polyvalente, Hôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris, Clamart, France.14Réanimation Polyvalente et USC, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France.15Réanimation chirurgicale, Centre Hospitalier Universitaire d'Amiens, Amiens, France.16Réanimation chirurgicale, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
• Crit. Care Med. 2017 Jul 1; 45 (7): e640-e648.

ObjectivesSolid neoplasms can be directly responsible for organ failures at the time of diagnosis or relapse. The management of such specific complications relies on urgent chemotherapy and eventual instrumental or surgical procedures, combined with advanced life support. We conducted a multicenter study to address the prognosis of this condition.DesignA multicenter retrospective (2001-2015) chart review.SettingMedical and respiratory ICUs.PatientsAdult patients who received urgent chemotherapy in the ICU for organ failure related to solid neoplasms were included. The modalities of chemotherapy, requirements of adjuvant instrumental or surgical procedures, and organ supports were collected. Endpoints were short- and long-term survival rates.InterventionsNone.Measurements And Main ResultsOne hundred thirty-six patients were included. Lung cancer was the most common malignancy distributed into small cell lung cancer (n = 57) and non-small cell lung cancer (n = 33). The main reason for ICU admission was acute respiratory failure in 111 patients (81.6%), of whom 89 required invasive mechanical ventilation. Compression and tissue infiltration by tumor cells were the leading mechanisms resulting in organ involvement in 78 (57.4%) and 47 (34.6%) patients. The overall in-ICU, in-hospital, 6-month, and 1-year mortality rates were 37%, 58%, 74%, and 88%, respectively. Small cell lung cancer was identified as an independent predictor of hospital survival. However, this gain in survival was not sustained since the 1-year survival rates of small cell lung cancer, non-small cell lung cancer, and non-lung cancer patients all dropped below 20%.ConclusionsUrgent chemotherapy along with aggressive management of organ failures in the ICU can be lifesaving in very selected cancer patients, most especially with small cell lung cancer, although the long-term survival is hardly sustainable.

21 keywords...

hide…